MARKET

ASND

ASND

Ascendis Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

111.71
-1.56
-1.38%
Opening 12:43 11/12 EST
OPEN
112.70
PREV CLOSE
113.27
HIGH
114.51
LOW
111.38
VOLUME
305.15K
TURNOVER
--
52 WEEK HIGH
133.96
52 WEEK LOW
53.21
MARKET CAP
5.31B
P/E (TTM)
-24.4063
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ASND and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ASND News

  • 5 Biotech Stocks Set to Beat Q3 Earnings Estimates
  • Zacks.1d ago
  • Ascendis Pharma A/S Announces Upcoming Investor Presentation in November
  • GlobeNewswire.3d ago
  • Ascendis Pharma A/S Announces First Presentation of Preclinical Data Utilizing TransCon Technology in Oncology at SITC 2019
  • GlobeNewswire.5d ago
  • CannTrust (CTST) to Report Q3 Earnings: What's in Store?
  • Zacks.11/05 16:50

More

Industry

Biotechnology & Medical Research
+0.07%
Pharmaceuticals & Medical Research
+0.49%

Hot Stocks

Name
Price
%Change

About ASND

Ascendis Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development. The Company is developing its product candidate, TransCon human growth hormone (TransCon hGH) for once-weekly administration to treat growth hormone deficiency (GHD) and other indications. In addition to TransCon hGH, the Company has developed a pipeline of long-acting prodrug product candidates, such as TransCon Treprostinil for the treatment of pulmonary arterial hypertension (PAH), TransCon Peptides for the treatment of diabetes and TransCon Ranibizumab for the treatment of ophthalmology. It is also using its TransCon technology platform to develop TransCon Parathyroid Hormone (TransCon PTH) for hypoparathyroidism, a rare endocrine disorder of calcium and phosphate metabolism.
More

Webull offers Ascendis Pharma A/S (ASND) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.